Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
The comment period closed Sep 10, 2026.
The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), and daridorexant ([(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrroli
Summary from the Federal Register.
Read the rule
Full history
- Aug 11, 2026
Rule published
Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
Justice Department
About this record
- Source
From the Federal Register. This record was last updated Sep 24, 2026. About our data
- What it is
A rule from Justice Department. Agora lists the comment window as the Federal Register gives it.
- Dates
Dates are in Eastern time.
This record shows the rule as proposed. A final rule, if any, is a separate Federal Register document.
- This page
Agora assembled this page from the Federal Register. The title and summary are the agency's, as the Federal Register prints them.